RSNA 2014 

Abstract Archives of the RSNA, 2014


SPSI21D

Panel Discussion

Special Courses

Presented on December 1, 2014
Presented as part of SPSI21: Special Interest Session: Radiology and Pathology Diagnostics: Is It Time to Integrate?

Participants

Mitchell Dennis Schnall MD, PhD, Presenter: Nothing to Disclose
Michael D. Feldman MD, PhD, Presenter: Nothing to Disclose
Martin Gilbert Pomper MD, PhD, Presenter: Grant, Eisai Co, Ltd Grant, Eli Lilly and Company Founder, Cancer Targeting Systems, Inc Board of Directors, Cancer Targeting Systems, Inc Founder, Theraly Pharmaceuticals Inc
Carolyn C. Meltzer MD, Presenter: Board of Directors, ACR Image Metrix
Curtis P. Langlotz MD, PhD, Presenter: Shareholder, Montage Healthcare Solutions, Inc Advisory Board, Reed Elsevier Advisory Board, Activate Networks, Inc Spouse, Consultant, Johnson & Johnson
Jeffrey C. Weinreb MD, Presenter: Nothing to Disclose

LEARNING OBJECTIVES

View learning objectives under main course title.

Cite This Abstract

Schnall, M, Feldman, M, Pomper, M, Meltzer, C, Langlotz, C, Weinreb, J, Panel Discussion.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002930.html